118
Views
26
CrossRef citations to date
0
Altmetric
Original Article

Expression and Production of Interleukin 4 in B-Cell Chronic Lymphocytic Leukaemia

, , &
Pages 689-698 | Received 24 Jan 2001, Published online: 01 Jul 2009

References

  • Royston R., Majda J. A., Baird S. M., Meserve B. L., Griffiths J. C. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. J Immunol 1980; 125: 725–731
  • Dighiero G., Travade P., Chevret S., Fenaux P., Chastang P., Binet J. L. The French Co-operative Group on CLL 1991 B-cell chronic lymphocytic leukaemia: present status and future directions. Blood, 78: 1901–1914
  • Collins R. J., Verschuer L. A., Harmon B. V., Prentice R. L., Pope J. H., Kerr J. F. Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol 1989; 71: 343–350
  • Dadmarz R., Rabinowe S. N., Cannistra S. A., Andersen J. W., Freedman A. S., Nadler L. M. Association between clonogenic cell growth and clinical risk group in B-cell chronic lymphocytic leukemia. Blood 1990; 76: 142–149
  • Hoffbrand A. V., Panayiotidis P., Reittie J., Ganesharguru K. Autocrine and paracrine growth loops in chronic lymphocytic leukaemia. Sem. Hematol 1993; 30: 306–317
  • Fluckiger A. C., Durand I., Banchereau J. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukaemia cells. J Exp Med 1994; 179: 91–99
  • Mainou-Fowler T., Craig V. A., Copplestone J. A., Hammon M. D., Prentice A. G. Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4. Blood 1994; 84: 2297–2304
  • Buschle M., Campana D., Carding S. R., Richard C., Hoffbrand A. V., Brenner M. K. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukaemia. J Exp Med 1993; 177: 213–218
  • Huang R. W., Tsuda H., Takatsuki K. Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells. Int J Hematol 1993; 58: 83–92
  • Dancescu M., Rubio-Trujillo M., Biron G., Bron D., Delespesse G., Sarfati M. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 1992; 176: 1319–1326
  • Yssel H., Schneider P., Spits H. Production of IL4 by human T cells and regulation of differentiation of T-cell subset by IL4. Res Immunol 1993; 144: 610–616
  • Callard R. E. Immunoregulation by interleukin-4 in man. Br J Haematol 1991; 78: 293–299
  • Mainou-Fowler T., Copplestone J. A., Prentice A. G. Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells. J Clin Pathol 1995; 18: 482–487
  • Tony H. P., Lehrnbecher T., Merz H., Sebald W., Wilhelm M. Regulation of IL-4 responsiveness in lymphoma B cells. Leuk Res 1991; 15: 911–919
  • Defrance T., Fruckiger A.-M., Rossi J.F., Roosset F., Banchereau J. In vitro activation of B-CLL cells. Leuk Lymphoma 1991; 13–19, Abstract
  • Carlsson M., Soderberg O., Nilsson K. Interleukin-4 enhances homotypic adhesion of activated B-chronic lymphocytic leukemia (B-CLL) cells via a selective upregulation of CD54. Scan. J Immunol 1993; 37: 515–522
  • Sarfati M., Bron D., Lagneaux L., Fonteyn C., Frost H., Delespesse G. Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia. Blood 1988; 71: 94–98
  • Sarfati M., Fournier S., Christoffersen M., Biron G. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia. Leuk Res 1990; 14: 47–55
  • Zwiebel J. A., Cheson B. D. Chronic lymphocytic leukemia: Staging and prognostic factors. Sem Oncol 1998; 25: 42–59
  • Mainou-Fowler T., Craig V. A., Copplestone J. A., Hamon M. D., Prentice A. G. Effect of anti-apolipoprotein-1 on spontaneous apoptosis of B cells in chronic lymphocytic leukaemia: the role of bcl-2 and Interleukin 4. Leuk Lymphoma 1995; 19: 301–308
  • Mentz F., Mossalayi M. D., Ouaaz F., Baudet S., Issaly F., Ktorza S., Semichon M., Binet J. L. Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukaemia cells. Blood 1996; 88: 2172–2182
  • Lundgren M., Persson U., Larsson P., Magnusson C., Smith Hammarstrom C. I.L., Severinson E. Interleukin 4 induces synthesis of IgE and IgG4 in human B cells. Eur Immunol 1989; 19: 1311–1315
  • Reyes E., Prieto A., Carrion F., Garcia-Suarez J., Esquivel F., Guillen C., Alvarez-Mon M. Altered pattern of cytokine production by peripheral blood CD2+ cells from B chronic lymphocytic leukaemia patients. Am J Hematol 1998; 57: 93–100
  • Mu X., Kay N. E., Gosland M. P., Jennings C. D. Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: evidence for increased levels of cytoplasmic IL-4 in resting and activated CD8 T cells. Br J Haematol 1997; 96: 733–735
  • Fais F., Ghiotto F., Hashimoto S., Sellars B., Valetto A., Allen S. L., Schulman P., Vinciguerra V. P., Rai K., Rassenti L. Z., Kipps T. J., Dighiero G., Schroeder H. W., Jr., Ferrarini M., Chiorazzi N. Chronic lymphocytic leukaemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 102: 1515–1525
  • Caligaris-Cappio F., Gobbi M., Bofill M., Janossy G. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 1982; 155: 623–628
  • de Totero D., Reato G., Mauro F., Cignetti A., Ferrini S., Guarini A., Gobbi M., Grossi C. E., Foa R. IL4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemia. Br J Haematol 1999; 104: 589–599
  • Decker T., Flohr T., Trautmann P., Aman M. J., Holter W., Majdic O., Huber C., Peschel C. Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia. Blood 1995; 86: 1115–1132
  • Schena M., Gaidano G., Gottardi D., Malavasi F., Larsson L. G., Nilsson K., Caligaris-Cappio F. Molecular investigation of the cytokines produced by normal and malignant B lymphocytes. Leukemia 1992; 6: 120–125
  • Plate J. M., Knospe W. H., Harris J. E., Gregory S. A. Normal and aberrant expression of cytokines in neoplastic cells from chronic lymphocytic leukemias. Hum Immunol 1993; 36: 249–258
  • Vellenga E., Dokter W. H., Halie R. M. Interleukin-4 and its receptor; modulating effects on immature and mature hematopoietic cells. Leukemia 1993; 7: 1131–1141
  • Borger P., Kauffman H. F., Postma D. S., Vellenga E. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood 1996; 87: 691–698
  • Dokter W. H., Esselink M. T., Sierdsema S. J., Halie M. R., Vellenga E. Transcriptional and posttranscriptional regulation of the interleukin-4 and interleukin-3 genes in human T cells. Blood 1993; 81: 35–40
  • John L., Kneitz C., Mehringer C., Milhelm M., Tony H. P. Regulation of IL-4 receptors (IL-4R) in human CD5-positive B-cell lymphomas. 9th International Congress of Immunology. San Francisco 1995, Abstract
  • Zola H., Flego L., Weedon H. Expression of IL-4 receptor on human a T and B lymphocytes. Cell Immunol 1993; 150: 149–158
  • Armitage R. J., Beckman M. P., Idzerda R. L., Alpert A., Fanslow W. C. Regulation of Interleukin 4 receptors on human T cells. Int Immunol 1990; 2: 1039–1045

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.